1.Ameloblastic carcinoma of the maxilla: a report of two cases and a review of the literature.
Benjamin FOMETE ; Ezekiel Taiwo ADEBAYO ; Godwin Iko AYUBA ; Uche Albert OKEKE
Journal of the Korean Association of Oral and Maxillofacial Surgeons 2016;42(1):43-46
Ameloblastic carcinoma is a malignant form of ameloblastoma defined by histological evidence of malignancy in primary, recurrent, or metastatic tumor. Such a tumor is rare, and the maxilla is an unusual site. Due to its rarity, the characteristics of this tumor in the maxilla have not been well described. Case 1: A 55-year-old, ill-appearing Nigerian male presented to our center with left maxillary swelling of seven-year duration. The swelling had been slow-growing and painless until one year prior, when the growth became rapid and was coupled with severe pain. The swelling affected both oral function and facial esthetics, and the patient reported difficulty breathing. There was a maxillary, ulcerated swelling extending from teeth 12 to 18 and blocking the left nostril. The involved teeth were moderately mobile. Case 2: A 32-year-old male farmer presented with recurrent right maxillary swelling of six-year duration. Prior to this episode, he had undergone surgery for ameloblastoma (follicular type). The present swelling was fungating through the skin and protruding into the right nostril. Ameloblastic carcinoma is an aggressive odontogenic tumor that requires aggressive surgical treatment.
Adult
;
Ameloblastoma
;
Ameloblasts*
;
Esthetics
;
Humans
;
Male
;
Maxilla*
;
Middle Aged
;
Odontogenic Tumors
;
Respiration
;
Skin
;
Tooth
;
Ulcer
2.Primary oral soft tissue angiosarcoma of the cheek: a case report and literature review.
Benjamin FOMETE ; Modupe SAMAILA ; Sunday EDAIGBINI ; Rowlan AGBARA ; Uche Albert OKEKE
Journal of the Korean Association of Oral and Maxillofacial Surgeons 2015;41(5):273-277
Angiosarcoma is a rare and aggressive malignant tumor that has a poor prognosis. It represents less than 1% of all malignancies occurring in the oral cavity and salivary glands. We present a 35-year-old male with angiosarcoma of the cheek following traumatic injury and a review of the current literature.
Adult
;
Cheek*
;
Hemangiosarcoma*
;
Humans
;
Male
;
Mouth
;
Prognosis
;
Salivary Glands